JPRN-UMIN000029015
Recruiting
未知
Efficacy of the medical compound of teneligliptin 20 mg and canagliflozin 100 mg with Free Style Libre - Efficacy of the medical compound of teneligliptin and canagliflozin with Free Style Libre
TDE Healthcare Corporation TOSAKI Clinic for Diabetes and Endocrinology0 sites40 target enrollmentSeptember 5, 2017
Conditionstype 2 diabetes mellitus
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- type 2 diabetes mellitus
- Sponsor
- TDE Healthcare Corporation TOSAKI Clinic for Diabetes and Endocrinology
- Enrollment
- 40
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. Patients who have renal dysfunction (eGFR is less than 30ml/min/1\.73m2\) 2\. Pregnant women 3\. Patients judged by the doctor to be ineligible
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 4
The efficacy of teneligliptin in diabetic patients on hemodialysisType2 diabetic patients on hemodialysisJPRN-UMIN000010999Kawashima Hospital30
Completed
Phase 3
Efficacy and Safety of Teneligliptin in Combination With Metformin in Chinese Patients With Type 2 Diabetes MellitusType 2 Diabetes MellitusNCT02924064Tanabe Pharma Corporation247
Completed
Not Applicable
Effects of one of antidiabetic agents, teneligliptin, on the vascular endothelium function of ACS patients with diabetesAcute Coronary Syndrome (ACS) and diabetesJPRN-UMIN000018936Saitama Medical Center, Jichi Medical University50
Completed
Not Applicable
The efficacy of teneligliptin in patients with type 2 diabetes mellitusJPRN-UMIN000028763Juntendo University Urayasu Hospital30
Completed
Not Applicable
Effects of Teneligliptin improvement endotherial dysfunction, inflammation, coagulation and oxidative stress in patients with coronary artery disease and diabetes, pilot study(Tiramisu study).Coronary artery diseaseJPRN-UMIN000011960Gunma University30